Study Stopped
Device Deficiency
3M Oral Rinse Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes
3M Oral Rinse Evaluation of Incidence and Patient Acceptance of Sloughing When Used With Sodium Lauryl Sulfate (SLS) Toothpastes
1 other identifier
interventional
53
1 country
1
Brief Summary
The primary objective of this study is to evaluate the incidence of oral tissue sloughing through self-report by study subjects and by professional dental examinations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2020
CompletedFirst Submitted
Initial submission to the registry
October 13, 2020
CompletedFirst Posted
Study publicly available on registry
October 23, 2020
CompletedResults Posted
Study results publicly available
November 19, 2021
CompletedOctober 1, 2024
September 1, 2024
2 months
October 13, 2020
September 16, 2021
September 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Oral Mucosal Exfoliation (Oral Sloughing)
Percentage of participants who experienced oral sloughing as reported either by the subject or determined by the dental evaluator.
End of treatment (3 weeks)
Secondary Outcomes (2)
The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores
Mid-Treatment (10 days)
The Number of Participants With a Given Range of Average Oral Mucosal Sloughing Index Scores.
End of Treatment (3 weeks)
Other Outcomes (1)
The Number of Participants Reporting Their Acceptance Levels of Side Effects
End of Treatment (3 weeks)
Study Arms (3)
Comparator: No SLS Toothpaste
EXPERIMENTAL3M Oral Rinse in combination with no SLS toothpaste (A)
Comparator: Medium SLS Toothpaste
EXPERIMENTAL3M Oral Rinse in combination with medium SLS toothpaste (B)
Comparator: High SLS Toothpaste
EXPERIMENTAL3M Oral Rinse in combination with high SLS toothpaste (C)
Interventions
Toothpaste no Sodium Lauryl Sulfate
Less than or equal to X ppm Sodium Lauryl Sulfate
More than or equal to X ppm Sodium Lauryl Sulfate
Rinse prevents bacterial adherence to teeth
Eligibility Criteria
You may qualify if:
- Able to understand and willing to sign the informed consent;
- Willing to agree to maintain confidentiality of the study and study materials;
- M employee aged 18 years and older;
- Willing to return to the study facility for scheduled study visits and recalls;
- Agree not to use other oral hygiene products (non-study toothpaste, non-study toothbrush, mouth rinse, chewing gum);
- Agree to the study instruction and schedule
You may not qualify if:
- A member of the Medical Clinical Affairs (MCA) staff or Panda product team for the device under investigation;
- Have a dental appointment scheduled during study duration for professional cleaning;
- Is pregnant, nursing, or planning to become pregnant within the study duration;
- History of antibiotic therapy within the previous 30 days or have a condition that is likely to need antibiotic treatment over the course of the study (e.g., cardiac conditions requiring antibiotic prophylaxis such as heart murmurs, pacemakers, or prosthetic heart valves and prosthetic implants);
- History of using a prescription antimicrobial mouth rinse during the past 3 months;
- Currently taking medications which may alter gingival appearance/bleeding;
- Currently using anticonvulsants, calcium channel blockers, or other medications with side effects known to impact oral health;
- Participation in any other clinical study within the last 30 days;
- Resides in the same household with a subject already enrolled in the study;
- Known history of sensitivity to oral hygiene products;
- Currently using tobacco products (cigarettes, chewing tobacco) or vaping products (ecigarettes);
- History of diabetes;
- Have removable partial/full dentures;
- Have orthodontic appliances;
- Have medical or oral conditions that may compromise the subject's safety or interfere with the conduct and outcome of the study;
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Solventum US LLClead
- 3Mcollaborator
Study Sites (1)
3M Health Care
Saint Paul, Minnesota, 55144, United States
Limitations and Caveats
The major limitation with this study is that the sample size goal was not reached given the early termination during the washout period of a two-period crossover design.
Results Point of Contact
- Title
- Brenda Coalwell, Clinical Affairs Manager
- Organization
- 3M Health Care Business Group
Study Officials
- PRINCIPAL INVESTIGATOR
Brenda C Coalwell, BA
3M Health Care Business Group
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Assessors did not know what toothpaste subjects used.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 13, 2020
First Posted
October 23, 2020
Study Start
January 6, 2020
Primary Completion
March 10, 2020
Study Completion
March 10, 2020
Last Updated
October 1, 2024
Results First Posted
November 19, 2021
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share